Last $44.09 USD
Change Today +0.60 / 1.38%
Volume 550.5K
SGEN On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 08/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Franklin M. Berger CFA, BA, MA, MBA

Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee, Five Prime Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 76 board members in 8 different organizations across 17 different industries.

See Board Relationships
64$51,994

Background*

Mr. Franklin M. Berger, CFA, BA, MA, MBA is the Founder and Principle of FMR Research Inc. Mr. Berger has been a Consultant to pharmaceutical and biotechnology companies, asset managers and venture capital firms since 2003. He served as the Managing Director of U.S. of Equity Research and Senior Biotechnology Analyst at J.P. Morgan Securities LLC from 1998 to 2003. While he was at the J.P. Morgan Securities Inc., his Research Group Maintained Coverage of 26 Biotechnology ...

Read Full Background

Corporate Headquarters*

21823 30th Drive SE
Bothell, Washington 98021

United States

Phone: 425-527-4000
Fax: 425-527-4001

Board Members Memberships*

Former Director
Director
Director
Former Director
Director
2003-2010
Former Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Nominating & Governance Committee
2004-2014
Former Director and Member of Audit Committee
2006-2011
Former Director, Chairman of Audit Committee and Member of Compensation, Corporate Governance & Nominating Committee
2007-Present
Lead Independent Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Corporate Governance & Nominating Committee
2009-2009
Former Director
2010-Present
Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
2010-Present
Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee
2013-2014
Former Director, Member of Audit Committee and Member of Compensation Committee
2013-2014
Former Director, Chairman of Compensation Committee and Member of Audit Committee
2014-Present
Director, Chairman of Audit Committee and Member of Compensation Committee
2014-Present
Director

Education*

MBA
Harvard Business School
MA
Johns Hopkins University
BA
Johns Hopkins University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$31,851
Total Calculated Compensation$51,994
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SGEN:US $44.09 USD +0.60

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SEATTLE GENETICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.